Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. In a patent, 1055361-35-7, name is 4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile, introducing its new discovery. HPLC of Formula: C19H11F3N2O4S
Discloses a ligand containing naphthenic the base is auxiliary organic light-emitting material, through the provision of a kind of metal complex to realize, this metal complex uses the novel containing an alkyl ketone structure of 5 auxiliary ligand. The metal complex can be used as the organic electroluminescent device of the luminous material in the light-emitting layer. By combining these novel ligand, can effectively improve the service life of the device, changing the sublimation property, improvement of the device performance. Also discloses an electroluminescent device and compound formulation. (by machine translation)
You can get involved in discussing the latest developments in this exciting area about HPLC of Formula: C19H11F3N2O4S, you can also check out more blogs about1055361-35-7
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H867N | ChemSpider